Age-Related Characteristics of SYT1-Associated Neurodevelopmental Disorder
Sam G. NorwitziD, Josefine EckiD, Joel S. WinstoniD, Kate BakeriD
Abstract
ObjectivesWe describe the clinical manifestations and developmental abilities of individuals with SYT1-associated neurodevelopmental disorder (Baker-Gordon syndrome) from infancy to adulthood. We further describe the neuroradiological and electrophysiological characteristics of the condition at different ages, and explore the associations between these characteristics and clinical symptoms. MethodsParticipants were recruited to the UK-based Brain and Behavior in Neurodevelopmental Disorders of Genetic Origin project. Caregivers completed a medical history questionnaire and a battery of standardized neurodevelopmental measures. MRI and EEG records were obtained with consent from treating clinicians. Age-related clinical manifestations and neuroimaging records were systematically analyzed. Accuracy testing was used to explore brain-symptom associations. ResultsThis study describes 39 individuals with 29 distinct de novo SYT1 missense variants, including 11 novel variants. Qualitative age-related clinical trends included the resolution of hypotonia and worsening of movement disorders, sleep difficulties, and self-injurious behaviors. Social-communicative impairments were prominent, with evidence of progression with age. MRI abnormalities were identified in 48% of individuals, while EEG abnormalities were present in 92%. Epileptiform activity frequently co-occurred with movement disorders, while irregular sleep EEG coincided with sleep difficulties and respiratory problems. InterpretationThis study characterizes the broad spectrum and age-related progression of clinical symptoms and brain-related findings in individuals with SYT1-associated neurodevelopmental disorder. Further research is needed to understand factors contributing to within-individual change, and to develop targeted interventions aimed at improving outcomes and quality of life for affected individuals and their families.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 1.17
- Field percentile
- top 20%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Expanding the genotype and phenotype spectrum of SYT1-associated neurodevelopmental disorder
Holly Melland, Fabian Bumbak, … Kate Baker·Genetics in MedicinePeer-reviewed·Jan 28, 2022
- Neurobehavioral Profiles and Clinical Consequences of MYT1L-Related Neurodevelopmental Disorder: Insights from the Brain Gene Registry.
Jorge Luis Granadillo, Levi Kaster, … Joseph D. Dougherty·American Journal of Medical Genetics Part APeer-reviewed·Oct 19, 2026
- Hyperexcitability and translational phenotypes in a preclinical model of SYNGAP1 mutations
Timothy A. Fenton, Olivia Y Haouchine, … Jill L. Silverman·bioRxiv·Jul 24, 2023
- Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome
Marjolein J.A. Weerts, Kristina Lanko, … Tahsin Stefan Barakat·Genetics in MedicinePeer-reviewed·Aug 3, 2021
- Variants in BSN, encoding the presynaptic protein Bassoon, result in a novel neurodevelopmental disorder with a broad phenotypic range
Stacy G. Guzman, Sarah McKeown Ruggiero, … Ingo Helbig·medRxiv·Feb 10, 2025
- Re-expression of SynGAP Protein in Adulthood Improves Translatable Measures of Brain Function and Behavior in a Model of Neurodevelopmental Disorders
Thomas K. Creson, Camilo Rojas, … Gavin Rumbaugh·eLifePeer-reviewed·Apr 26, 2019